The oral insulin sensitiser INS-1 improves ovulation and has beneficial cardiovascular effects in lean women with polycystic ovary syndrome

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1245, 2000-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metformin monotherapy in lean women with polycystic ovary syndrome

By Kumari AS   Haq A   Jayasundaram R   Abdel-Wareth LO   al Haija SA   Alvares M  

Reproductive BioMedicine Online, Vol. 10, Iss. 1, 2005-01 ,pp. : 100-104

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Insulin Gene Polymorphism in Women with Polycystic Ovary Syndrome

By Ferk P   Perme MP   Geršak K  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1180-1187

Field House Publishing

Access to resources Recommend Favorite

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

By Orio Francesco   Palomba Stefano   Cascella Teresa   Tauchmanovà Libuse   Nardo Luciano G.   Di Biase Sebastiano   Labella Donato   Russo Tiziana   Savastano Silvia   Tolino Achille   Zullo Fulvio   Colao Annamaria   Lombardi Gaetano  

Reproductive BioMedicine Online, Vol. 10, Iss. 2, 2005-02 ,pp. : 289-292

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

By Orio Francesco   Palomba Stefano   Cascella Teresa   Tauchmanovà Libuse   Nardo Luciano G   Di Biase Sebastiano   Labella Donato   Russo Tiziana   Savastano Silvia   Tolino Achille   Zullo Fulvio   Colao Annamaria   Lombardi Gaetano  

Reproductive BioMedicine Online, Vol. 9, Iss. 5, 2004-11 ,pp. : 505-510

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Insulin Resistance and Polycystic Ovary Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 36, 2016-11 ,pp. : 5526-5534

Bentham Science Publishers

Access to resources Recommend Favorite